International society for the study of xenobiotics - 11th European meeting.
Cali
James J
JJ
Promega Corp, Madison, WI 53711, USA. jim.cali@promega.com
D000818:Animals; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D023421:Models, Animal; D009696:Nucleic Acids / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D004364:Pharmaceutical Preparations / Q000008:administration & dosage / Q000378:metabolism; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D015262:Xenobiotics / Q000378:metabolism*
D000911:Antibodies, Monoclonal; D009696:Nucleic Acids; D004364:Pharmaceutical Preparations; D011994:Recombinant Proteins; D015262:Xenobiotics